1996
DOI: 10.1378/chest.109.5.1234
|View full text |Cite
|
Sign up to set email alerts
|

Thoracoscopic Management of Malignant Pleural Effusions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0
2

Year Published

1996
1996
2010
2010

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(26 citation statements)
references
References 31 publications
1
23
0
2
Order By: Relevance
“…Our data are in agreement with those of previous studies showing that talc is the pleurodesis agent of preference. (10)(11)(12)(13) Other agents, such as bleomycin and doxycycline, are not routinely used in South or Central America. However, approximately 10% of the respondents in Brazil reported using silver nitrate.…”
Section: Survivalmentioning
confidence: 99%
“…Our data are in agreement with those of previous studies showing that talc is the pleurodesis agent of preference. (10)(11)(12)(13) Other agents, such as bleomycin and doxycycline, are not routinely used in South or Central America. However, approximately 10% of the respondents in Brazil reported using silver nitrate.…”
Section: Survivalmentioning
confidence: 99%
“…However, less invasive procedures, such as a thoracoscopic approach and partial parietal pleurectomy, have shown efficacy in the management of MPE for highly selected patients [88,89].…”
Section: Surgical Managementmentioning
confidence: 99%
“…When two or more studies of the pleural fluid including closed pleural biopsy fail to provide a diagnosis, a more invasive procedure such as thoracoscopic biopsy is probably the optimal choice because it has a lower risk than thoracotomy and has a diagnostic yield of 87% [1]. However, thoracoscopic procedures require general anaesthesia and have greater morbidity rates compared with a simple thoracentesis in this group of compromised patients with limited cardiorespiratory functions.…”
Section: Discussionmentioning
confidence: 99%
“…Although the diagnostic yield can reach up to 87% with more invasive thoracoscopic procedures, diagnosis of pleural effusions can be established in 33-72% of patients by conventional diagnostic methods [1][2][3]. Numerous procedures, including immunocytochemistry, chromosome analysis, tissue culture techniques, deoxyribonucleic acid (DNA) flow or image cytometry, and cell imaging combined with immunocytochemistry have been proposed for the differential diagnosis of pleural effusions to improve the sensitivity of cytological examination [4].…”
mentioning
confidence: 99%